All news

Link between ADT and cardiovascular death not found

Added: Saturday 25 February 2012

A pooled analysis of medical research databases found no evidence that androgen deprivation therapy (ADT) increases cardiovascular mortality. In addition, the use of ADT in men with unfavorable-risk prostate cancer was found to be associated with improved prostate cancer–specific survival and overall survival. ADT is frequently used in treating prostate cancer, but there has been controversy about a possible link between ADT and cardiovascular deaths.